Anti‐HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin

Saved in:

Bibliographic Details
Published in:	Journal of thrombosis and haemostasis Vol. 4; no. 2; pp. 469 - 470
Main Authors:	YAMAMOTO, K., HONDA, T., MATSUSHITA, T., KOJIMA, T., TAKAMATSU, J.
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Science Inc 01-02-2006
Subjects:	Adult Antiviral Agents - pharmacology Cells, Cultured Factor VII - genetics Factor VII - metabolism Gene Expression - drug effects Hemophilia A - blood Hemophilia A - complications Hemophilia A - drug therapy Hemophilia B - blood Hemophilia B - complications Hemophilia B - drug therapy Hepacivirus - drug effects Hepatitis C, Chronic - blood Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Hepatocytes - drug effects Hepatocytes - metabolism Humans Male Middle Aged Ribavirin - pharmacology RNA, Messenger - biosynthesis RNA, Messenger - genetics
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
ISSN:	1538-7933 1538-7836 1538-7836
DOI:	10.1111/j.1538-7836.2006.01761.x